What is he best known for?
The fields of study he is best known for:
His primary areas of study are microRNA, Cancer research, Cancer, Gene and Genetics.
His studies in microRNA integrate themes in fields like Gene expression, Gene expression profiling, Bioinformatics, Regulation of gene expression and Gene silencing.
His research integrates issues of Cell growth, Immunology, Cell cycle, Lung cancer and Epigenetics in his study of Cancer research.
Bladder cancer is closely connected to Pathology in his research, which is encompassed under the umbrella topic of Cancer.
His Gene research focuses on Molecular biology and how it connects with Cisplatin, Cellular differentiation and Transcriptome.
While the research belongs to areas of Genetics, George A. Calin spends his time largely on the problem of Cell biology, intersecting his research to questions surrounding Chromatin immunoprecipitation.
His most cited work include:
- MicroRNA signatures in human cancers (5424 citations)
- A microRNA expression signature of human solid tumors defines cancer gene targets (4837 citations)
- Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia (4145 citations)
What are the main themes of his work throughout his whole career to date?
George A. Calin focuses on microRNA, Cancer research, Cancer, Gene and Bioinformatics.
His microRNA study necessitates a more in-depth grasp of Genetics.
In his research, Tumor microenvironment is intimately related to Cancer cell, which falls under the overarching field of Cancer research.
His studies deal with areas such as Disease, Pathology and Oncology as well as Cancer.
His research in Gene tackles topics such as Computational biology which are related to areas like RNA.
His Regulation of gene expression research includes themes of Molecular biology and Cell biology.
He most often published in these fields:
- microRNA (61.56%)
- Cancer research (41.86%)
- Cancer (29.55%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (41.86%)
- microRNA (61.56%)
- Cancer (29.55%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, microRNA, Cancer, Computational biology and Non-coding RNA.
His Cancer research research incorporates themes from Carcinogenesis, Cancer cell, Tumor microenvironment, Metastasis and Long non-coding RNA.
His study in Cancer cell is interdisciplinary in nature, drawing from both Angiogenesis, Gene expression and Downregulation and upregulation.
His research in microRNA focuses on subjects like Triple-negative breast cancer, which are connected to Gene silencing and Cell growth.
His study looks at the relationship between Cancer and fields such as Oncology, as well as how they intersect with chemical problems.
His research in Computational biology intersects with topics in RNA, Genome, Gene and Liquid biopsy.
Between 2017 and 2021, his most popular works were:
- Clinical utility of circulating non-coding RNAs — an update (158 citations)
- MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance (76 citations)
- SnapShot: Unconventional miRNA Functions. (70 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are microRNA, Cancer research, Cancer, Computational biology and RNA.
George A. Calin studies Non-coding RNA which is a part of microRNA.
His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Cancer cell, Metastasis and Long non-coding RNA.
George A. Calin interconnects Malignant transformation, Malignancy, Disease and Meta-analysis in the investigation of issues within Cancer.
George A. Calin usually deals with Malignancy and limits it to topics linked to Multiple target and Lung cancer and Gene.
His Computational biology research integrates issues from Snapshot, Genome, Function, Human cancer and Cancer biomarkers.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
